Impact of diabetes mellitus on postoperative outcomes in individuals with non-small-cell lung cancer: A retrospective cohort study

Author:

Komatsu TeruyaORCID,Chen-Yoshikawa Toyofumi F.,Ikeda Masaki,Takahashi Koji,Nishimura Akiko,Harashima Shin-ichi,Date Hiroshi

Abstract

Objectives Studies showing that individuals with non-small cell lung cancer (NSCLC) and diabetes mellitus (DM) have reported poor outcomes after pulmonary resection with varying results. Therefore, we investigated the clinical impact of preoperative DM on postoperative morbidity and survival in individuals with resectable NSCLC. Patients and methods Data of individuals who underwent pulmonary resection for NSCLC from 2000 to 2015 were extracted from the database of Kyoto University Hospital. The primary endpoint was the incidence of postoperative complications, and secondary endpoints were postoperative length of hospital stay and overall survival. The survival rate was analyzed using the Kaplan–Meier method. Results A total of 2,219 patients were eligible for the study. The median age of participants was 67 years. Among them, 39.5% were women, and 259 (11.7%) presented with DM. The effect of DM on the incidence of postoperative complications and postoperative length of hospital stay was not significant. Although the 5-year survival rates were similar in both patients with and without DM (80.2% versus 79.4%; p = 0.158), those with DM who had a hemoglobin A1c level ≥ 8.0% had the worst survival. Conclusions In individuals with resectable NSCLC, preoperative DM does not influence the acute phase postoperative recovery. However, poorly controlled preoperative DM could lead to low postoperative survival rates.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference30 articles.

1. The Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group: past activities, current status and future direction;K Nakagawa;Japanese journal of clinical oncology,2017

2. Cancer statistics, 2016;RL Siegel;CA: a cancer journal for clinicians,2016

3. Trends in net survival lung cancer in six European Latin countries: results from the SUDCAN population-based study;A Bordoni;European journal of cancer prevention: the official journal of the European Cancer Prevention Organisation (ECP),2017

4. Federation. ID. IDF Diabetes Atlas, 8th edn. Brussels, Belgium: International Diabetes Federation.; 2017. Available from: http://www.diabetesatlas.org.

5. Patient outcomes from lung cancer and diabetes mellitus: a matched case-control study;NJ Karlin;Future science OA,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3